MRTX - Mirati Therapeutics GAAP EPS of -$3.40 beats by $0.17 revenue of $0.71M beats by $0.53M May, 04 2022 04:41 PM Mirati Therapeutics Inc. Mirati Therapeutics press release (NASDAQ:MRTX): Q1 GAAP EPS of -$3.40 beats by $0.17. Revenue of $0.71M beats by $0.53M. For further details see: Mirati Therapeutics GAAP EPS of -$3.40 beats by $0.17, revenue of $0.71M beats by $0.53M